-
公开(公告)号:US09951133B2
公开(公告)日:2018-04-24
申请号:US15171128
申请日:2016-06-02
Applicant: GENENTECH, INC.
Inventor: Shang-Fan Yu , Wei-Ching Liang , Yan Wu , Steven Leong , Andrew Polson
IPC: A61K39/395 , C07K16/28 , A61K47/48 , G01N33/574 , A61K39/00
CPC classification number: C07K16/2803 , A61K47/6809 , A61K47/6849 , A61K2039/505 , C07K2317/33 , C07K2317/73 , C07K2317/77 , C07K2317/92 , G01N33/57492 , G01N2333/70596 , G01N2458/00
Abstract: The invention provides anti-CD33 antibodies and immunoconjugates and methods of using the same.
-
公开(公告)号:US09884919B2
公开(公告)日:2018-02-06
申请号:US15214160
申请日:2016-07-19
Applicant: GENENTECH, INC.
Inventor: Yongmei Chen , James Ernst , Hok Seon Kim , Junichiro Sonoda , Christoph Spiess , Scott Stawicki , Yan Wu
IPC: A61K39/395 , C07K16/40 , C07K14/71 , C07K16/28 , A61K39/00
CPC classification number: C07K16/40 , A61K2039/505 , C07K14/71 , C07K16/2863 , C07K2317/21 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/34 , C07K2317/40 , C07K2317/41 , C07K2317/51 , C07K2317/515 , C07K2317/524 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/71 , C07K2317/75 , C07K2317/92
Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
-
公开(公告)号:US09879094B2
公开(公告)日:2018-01-30
申请号:US15234649
申请日:2016-08-11
Applicant: Genentech, Inc.
Inventor: Jasvinder Atwal , Yongmei Chen , Cecilia Pui Chi Chiu , Robert A. Lazarus , Weiru Wang , Ryan J. Watts , Yan Wu , Yingnan Zhang
IPC: C07H21/04 , C07K16/18 , C12P21/08 , C07K16/40 , A61K39/395 , G01N33/573 , C12P21/00 , A61K47/68 , A61K39/00
CPC classification number: C07K16/40 , A61K39/3955 , A61K47/6871 , A61K2039/505 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , C12P21/005 , G01N33/573
Abstract: The invention provides antibodies to specific neural proteins and methods of using the same.
-
公开(公告)号:US09873748B2
公开(公告)日:2018-01-23
申请号:US14582100
申请日:2014-12-23
Applicant: GENENTECH, INC.
Inventor: Yongmei Chen , James Ernst , Hok Seon Kim , Junichiro Sonoda , Christoph Spiess , Scott Stawicki , Yan Wu
CPC classification number: C07K16/40 , A61K2039/505 , C07K14/71 , C07K16/2863 , C07K2317/21 , C07K2317/24 , C07K2317/31 , C07K2317/33 , C07K2317/34 , C07K2317/40 , C07K2317/41 , C07K2317/51 , C07K2317/515 , C07K2317/524 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/71 , C07K2317/75 , C07K2317/92
Abstract: The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
-
公开(公告)号:US09845354B2
公开(公告)日:2017-12-19
申请号:US15053964
申请日:2016-02-25
Applicant: Genentech, Inc.
Inventor: Yan Wu , Minhong Yan
CPC classification number: C07K16/28 , A61K2039/505 , C07K16/18 , C07K16/22 , C07K16/2866 , C07K2317/24 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: The invention provides anti-EphrinB2 antibodies, and compositions comprising and methods of using these antibodies.
-
公开(公告)号:US09738727B2
公开(公告)日:2017-08-22
申请号:US13651289
申请日:2012-10-12
Applicant: Genentech, Inc.
Inventor: Yan Wu , Menno van Lookeren-Campagne , Daniel Kirchhofer , Michael Terry Lipari , Kenneth J. Katschke, Jr. , Paul M. Moran , Scott Stawicki , Wei-Ching Liang
IPC: C07K16/40
CPC classification number: C07K16/40 , C07K2317/34 , C07K2317/76 , C07K2317/92
Abstract: The invention provides anti-HtrA1 antibodies and methods of using the same.
-
公开(公告)号:US20170233486A1
公开(公告)日:2017-08-17
申请号:US15359098
申请日:2016-11-22
Applicant: Genentech, Inc.
Inventor: Christian W. Siebel , Yan Wu
IPC: C07K16/30
CPC classification number: C07K16/30 , A61K39/3955 , A61K45/06 , A61K2039/505 , C07K14/705 , C07K14/71 , C07K16/18 , C07K16/28 , C07K16/2863 , C07K16/3015 , C07K2317/14 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C12N5/10 , C12N5/12 , C12N15/09 , C12N15/63 , C12N2330/50
Abstract: The invention provides anti-Notch1 NRR antibodies, and compositions comprising and methods of using these antibodies.
-
公开(公告)号:US20170137531A1
公开(公告)日:2017-05-18
申请号:US15297390
申请日:2016-10-19
Applicant: Genentech, Inc.
Inventor: Yvonne Chinn , Julie Q. Hang , Christian W. Siebel , Yan Wu
IPC: C07K16/28
CPC classification number: C07K16/2896 , A61K39/3955 , A61K47/6849 , A61K2039/505 , A61K2039/507 , C07K16/28 , C07K2317/21 , C07K2317/33 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: The invention provides anti-Jagged1 antibodies and methods of using the same.
-
公开(公告)号:US09556267B2
公开(公告)日:2017-01-31
申请号:US14466794
申请日:2014-08-22
Applicant: Genentech, Inc.
Inventor: Eric Bourhis , Rick Carano , Andrea Cochran , Mike Costa , Venita DeAlmeida , James Ernst , Yan Gong , Rami Hannoush , Paul Polakis , Bonnee Rubinfeld , Mark Solloway , Yan Wu
IPC: A61K39/395 , C07K16/28 , A61K39/00
CPC classification number: C07K16/28 , A61K39/3955 , A61K2039/505 , A61K2039/507 , C07K16/2863 , C07K2317/21 , C07K2317/31 , C07K2317/34 , C07K2317/526 , C07K2317/55 , C07K2317/75 , C07K2317/76 , C07K2317/92 , C07K2319/00
Abstract: The invention provides anti-LRP6 antibodies and methods of using the same. A particular aspect of the invention provides for bispecific anti-LRP6 antibodies that inhibit signaling by multiple Wnt isoforms.
Abstract translation: 本发明提供抗LRP6抗体及其使用方法。 本发明的一个特定方面提供了抑制多种Wnt同种型的信号通路的双特异性抗LRP6抗体。
-
公开(公告)号:US09512217B2
公开(公告)日:2016-12-06
申请号:US14148414
申请日:2014-01-06
Applicant: Genentech, Inc.
Inventor: Yongmei Chen , Yan (Helen) Hu , Wenjun Ouyang , Scott Stawicki , Yan Wu
IPC: A61K39/395 , C07K16/24
CPC classification number: C07K16/244 , C07K2317/31 , C07K2317/34 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/92
Abstract: The present invention relates generally to antibodies cross-reactive with IL-17A and IL-17F, and bispecific anti-IL-17A/F and their uses.
Abstract translation: 本发明一般涉及与IL-17A和IL-17F交叉反应的抗体,以及双特异性抗IL-17A / F及其用途。
-
-
-
-
-
-
-
-
-